123
Participants
Start Date
December 22, 2021
Primary Completion Date
December 15, 2022
Study Completion Date
December 15, 2022
Trifarotene Cream
Participants will apply a thin a layer of trifarotene (CD5789) 50 mcg/g cream on the face once daily, in the evening for 24 weeks
Trifarotene Vehicle Cream
Participants will apply a thin a layer of trifarotene vehicle cream on the face once daily, in the evening for 24 weeks
Galderma Investigational Site #8620, New York
Galderma Investigational Site #9956, New York
Galderma Investigational Site #9949, New York
Galderma Investigational Site #8012, Glenn Dale
Galderma Investigational Site #9948, Hyattsville
Galderma Investigational Site #8184, Maitland
Galderma Investigational Site #7012, Lutz
Galderma Investigational Site #8764, Tampa
Galderma Investigational Site #6277, Pontevedra
Galderma Investigational Site #8207, Nashville
Galderma Investigational Site #6278, Manises
Galderma Investigational Site #9950, Evansville
Galderma Investigational Site #8554, Detroit
Galderma Investigational Site #6192, Zaragoza
Galderma Investigational Site #8606, New Orleans
Galderma Investigational Site #9952, Baton Rouge
Galderma Investigational Site #9953, Tulsa
Galderma Investigational Site #9920, Arlington
Galderma Investigational Site #8329, San Antonio
Galderma Investigational Site #8433, San Antonio
Galderma Investigational Site #8108, Las Vegas
Galderma Investigational Site #8358, San Diego
Galderma Investigational Site #9955, San Diego
Galderma Investigational Site #8636, Fountain Valley
Galderma Investigational Site #8224, Fremont
Lead Sponsor
Galderma R&D
INDUSTRY